Recent progress in nanotechnology-based novel drug delivery systems in designing of cisplatin for cancer therapy: an overview

Cisplatin cis-(diammine)dichloridoplatinum(II) (CDDP) is the first platinum-based complex approved by the food and drug administration (FDA) of the United States (US). Cisplatin is the first line chemotherapeutic agent used alone or combined with radiations or other anti-cancer agents for a broad ra...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Muhammad Asim Farooq, Md Aquib, Anum Farooq, Daulat Haleem Khan, Mily Bazezy Joelle Maviah, Mensura Sied Filli, Samuel Kesse, Kofi Oti Boakye-Yiadom, Rukhshona Mavlyanova, Amna Parveen, Bo Wang
Format: Artigo
Langue:Inglês
Publié: Taylor & Francis Group 2019-12-01
Collection:Artificial Cells, Nanomedicine, and Biotechnology
Sujets:
Cisplatin
drug delivery system
polymeric nanoparticles
cancer
nanotechnology
inorganic carriers
Accès en ligne:https://www.tandfonline.com/doi/10.1080/21691401.2019.1604535
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires